Quantcast

Latest Inhaler Stories

2011-01-18 08:00:00

AUSTIN, TX, Jan. 18 /PRNewswire-FirstCall/ - PharmaForm, a leader in pharmaceutical formulation and clinical manufacturing, today announced several corporate updates including the hire of several key scientists and investment in capital equipment that will allow the company to significantly expand in 2011.  PharmaForm announced today the appointment of J. Blair West, Ph.D., as Vice President of Pharmaceutical Operations. Dr. West brings over 20 years of experience as a senior...

2010-12-01 07:00:00

REDWOOD CITY, Calif., Dec. 1, 2010 /PRNewswire/ -- Pearl Therapeutics Inc. today announced that their lead combination bronchodilator, PT003, met the primary efficacy endpoint in a recently completed Phase 2b clinical trial in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). These top-line results show that PT003 provides superior bronchodilation compared to the current market leader, tiotropium bromide (Spiriva®...

2010-11-10 16:31:00

EXTON, Pa., Nov. 10, 2010 /PRNewswire/ -- Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for respiratory and immune disorders, will present ARIDOL(TM) (mannitol inhalation powder) Bronchial Challenge Test Kit, at the 2010 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), November 11-16 in Phoenix, AZ. Approved by the U.S. Food and Drug Administration (FDA) on October 5, 2010, ARIDOL is the first new bronchial...

2010-11-02 07:37:00

WILMINGTON, Del., Nov. 2, 2010 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that results from TITAN, a 12-week study of SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol in African American patients with moderate to severe persistent asthma, showed significant improvement in lung function for patients taking SYMBICORT compared with those using budesonide alone.(1) Safety and efficacy results from the TITAN study(1,2) are...

2010-10-25 12:25:28

University of Maryland School of Maryland researchers show bitter compounds open lung airways better than current drugs Taste receptors in the lungs? Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the receptors could revolutionize the treatment of asthma and other obstructive lung diseases. "The detection of functioning taste...

2010-10-21 11:24:00

LOURES, Portugal, October 21, 2010 /PRNewswire/ -- Hovione has been advised by Daiichi Sankyo Company Ltd that Inavir(R) has been launched in Japan. Inavir(R) is an inhalation powder which is delivered by the TwinCaps(R) inhaler to treat influenza. TwinCaps(R) was specifically designed by Hovione for this indication and is licensed to Daiichi Sankyo and to Biota Holdings Ltd. Daiichi Sankyo has demonstrated that one 40mg dose of Inavir(R) active ingredient, laninamivir...

2010-10-19 08:00:00

REDWOOD CITY, Calif., Oct. 19 /PRNewswire/ -- Pearl Therapeutics Inc., a privately held company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $69 million Series C financing. The financing round was led by Vatera Healthcare Partners and included existing investors, Clarus Ventures, New Leaf Venture Partners and 5AM Ventures. With this...

2010-10-19 07:18:00

HORSHAM, Pa., Oct. 19 /PRNewswire/ -- Teva Respiratory announced today the launch of EIB Active, a national health campaign to raise awareness about exercise-induced bronchospasm, or EIB, a condition that impacts an estimated 30 million people in the United States. EIB is a treatable condition that causes wheezing, coughing and chest tightness during or immediately following exercise or physical activity. Despite the large number of people living with EIB, diagnosis remains low due to a...

2010-09-20 18:45:13

Tiotropium bromide effective when added to low-dose inhaled corticosteroids A drug commonly used for the treatment of chronic obstructive pulmonary disease (COPD) successfully treats adults whose asthma is not well-controlled on low doses of inhaled corticosteroids, reported researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. "This study's results show that tiotropium bromide might provide an alternative to other asthma...

2010-09-14 09:07:00

LOURES, Portugal, September 14, 2010 /PRNewswire/ -- Hovione is announcing the approval in Japan of Inavir(R), Dry Powder Inhaler 20mg, for treatment of influenza. This approval has been granted to Daiichi Sankyo Company Ltd, a licensee of Hovione for the TwinCaps(R) inhaler which delivers the drug to the lungs. Hovione developed the TwinCaps(R) inhaler specifically for this indication. Inavir(R) directly delivers the drug to the infected airways of influenza patients, and a single...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related